糖尿病与新冠病毒疾病严重程度的关联：来自调整后效应估计的证据。 - Suppr

Suppr

超能文献

The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates.

作者信息

Liang Xuan, Xu Jie, Xiao Wenwei, Shi Li, Yang Haiyan

机构信息

Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, 450001, China.

出版信息

Hormones (Athens). 2021 Jun;20(2):409-414. doi: 10.1007/s42000-020-00259-x. Epub 2020 Nov 25.

DOI:10.1007/s42000-020-00259-x

PMID:33236191

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685958/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c95/7685958/e1fbae717eab/42000_2020_259_Fig1_HTML.jpg

相似文献

The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates.糖尿病与新冠病毒疾病严重程度的关联：来自调整后效应估计的证据。

Hormones (Athens). 2021 Jun;20(2):409-414. doi: 10.1007/s42000-020-00259-x. Epub 2020 Nov 25.

Diabetes and COVID-19: A pooled analysis related to disease severity and mortality.糖尿病与 COVID-19：与疾病严重程度和死亡率相关的汇总分析。

Prim Care Diabetes. 2021 Feb;15(1):24-27. doi: 10.1016/j.pcd.2020.08.015. Epub 2020 Aug 29.

Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19.性别与SARS-CoV-2感染以及因COVID-19导致住院之间的关联。

Lancet Respir Med. 2021 Aug;9(8):e75-e76. doi: 10.1016/S2213-2600(21)00239-3. Epub 2021 Jun 18.

Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).肥胖症和糖尿病是导致 2019 年冠状病毒病（COVID-19）重症的高危因素。

Diabetes Metab Res Rev. 2021 Feb;37(2):e3377. doi: 10.1002/dmrr.3377. Epub 2020 Jul 20.

Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19?未控制的糖尿病患者感染 COVID-19 的风险高吗？

Prim Care Diabetes. 2021 Feb;15(1):18-20. doi: 10.1016/j.pcd.2020.08.002. Epub 2020 Aug 7.

Diabetes, obesity and COVID-19: A complex interplay.糖尿病、肥胖与 COVID-19：复杂的相互作用。

Diabetes Obes Metab. 2020 Oct;22(10):1892-1896. doi: 10.1111/dom.14134. Epub 2020 Jul 28.

COVID-19 in patients with hidradenitis suppurativa.化脓性汗腺炎患者中的新型冠状病毒肺炎

Br J Dermatol. 2021 Jan;184(1):182-184. doi: 10.1111/bjd.19492. Epub 2020 Sep 24.

One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.在糖尿病和 COVID-19 大流行冲突的一年中：经验教训和未来展望。

J Diabetes Investig. 2022 Jan;13(1):19-21. doi: 10.1111/jdi.13644. Epub 2021 Sep 1.

Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis.心血管和代谢疾病对新型冠状病毒肺炎严重程度的影响：一项系统综述和荟萃分析

Aging (Albany NY). 2020 Nov 16;12(22):23409-23421. doi: 10.18632/aging.103991.

Coronavirus infection in a high-risk obstetrical population of the South Bronx, New York.纽约市布朗克斯区南部高危产科人群中的冠状病毒感染情况。

Am J Obstet Gynecol MFM. 2020 Nov;2(4):100203. doi: 10.1016/j.ajogmf.2020.100203. Epub 2020 Aug 18.

引用本文的文献

The Effect of SARS-CoV-2 Spike Protein RBD-Epitope on Immunometabolic State and Functional Performance of Cultured Primary Cardiomyocytes Subjected to Hypoxia and Reoxygenation.新型冠状病毒刺突蛋白 RBD 表位对缺氧/复氧培养原代心肌细胞免疫代谢状态和功能表现的影响。

Int J Mol Sci. 2023 Nov 21;24(23):16554. doi: 10.3390/ijms242316554.

The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course-A Narrative Review.糖尿病和高血糖对新型冠状病毒肺炎感染病程的影响——一篇叙述性综述

Front Clin Diabetes Healthc. 2022 Mar 10;3:812134. doi: 10.3389/fcdhc.2022.812134. eCollection 2022.

Assisting individuals with diabetes in the COVID-19 pandemic period: Examining the role of religious factors and faith communities.在2019冠状病毒病大流行期间协助糖尿病患者：审视宗教因素和宗教团体的作用。

World J Clin Cases. 2022 Sep 16;10(26):9180-9191. doi: 10.12998/wjcc.v10.i26.9180.

Significant association between anemia and higher risk for COVID-19 mortality: A meta-analysis of adjusted effect estimates.贫血与 COVID-19 死亡率升高显著相关：调整效应估计的荟萃分析。

Am J Emerg Med. 2022 Aug;58:281-285. doi: 10.1016/j.ajem.2022.06.030. Epub 2022 Jun 22.

First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome.首个在印度西部人群中开展的全基因组关联研究报告揭示了宿主遗传因素对 COVID-19 严重程度和结局的影响。

Genomics. 2022 Jul;114(4):110399. doi: 10.1016/j.ygeno.2022.110399. Epub 2022 Jun 6.

Significant association between ischemic heart disease and elevated risk for COVID-19 mortality: A meta-analysis.缺血性心脏病与新冠病毒疾病死亡风险升高之间的显著关联：一项荟萃分析。

Am J Emerg Med. 2022 May;55:95-97. doi: 10.1016/j.ajem.2022.03.010. Epub 2022 Mar 9.

COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data.COVID-19 院内死亡率在糖尿病患者中由合并症和年龄倾向评分匹配的奥地利国家公共卫生研究所数据分析驱动。

Viruses. 2021 Nov 30;13(12):2401. doi: 10.3390/v13122401.

Evaluation and management of COVID-19-related severity in people with type 2 diabetes.评估和管理 2 型糖尿病患者 COVID-19 相关严重程度。

BMJ Open Diabetes Res Care. 2021 Sep;9(1). doi: 10.1136/bmjdrc-2021-002299.

Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia.2019冠状病毒病肺炎患者的既往糖尿病与新冠病毒相关高血糖症

Biology (Basel). 2021 Aug 5;10(8):754. doi: 10.3390/biology10080754.

Lack of Marked Association Between Gastrointestinal Symptoms and COVID-19 Mortality: An Updated Meta-analysis Based on Adjusted Effect Estimates.胃肠道症状与新冠病毒疾病死亡率之间缺乏显著关联：基于校正效应估计值的最新荟萃分析

Mayo Clin Proc. 2021 Jun;96(6):1672-1680. doi: 10.1016/j.mayocp.2021.04.011. Epub 2021 Apr 20.

本文引用的文献

Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients.糖尿病与 COVID-19 住院患者的院内死亡率增加相关：一项包含 18506 例患者的系统评价和荟萃分析。

Hormones (Athens). 2021 Jun;20(2):305-314. doi: 10.1007/s42000-020-00246-2. Epub 2020 Oct 29.

Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: a Nationwide Case-Control Study.韩国基础合并症对 COVID-19 感染和严重程度的影响：一项全国性病例对照研究。

J Korean Med Sci. 2020 Jun 29;35(25):e237. doi: 10.3346/jkms.2020.35.e237.

Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19.肥胖与 COVID-19 住院患者的死亡率增加相关。

Obesity (Silver Spring). 2020 Oct;28(10):1806-1810. doi: 10.1002/oby.22941. Epub 2020 Aug 25.

Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience.慢性肝脏疾病对 COVID-19 住院患者结局的影响：美国多中心经验。

Liver Int. 2020 Oct;40(10):2515-2521. doi: 10.1111/liv.14583. Epub 2020 Jul 5.

Diabetes increases the mortality of patients with COVID-19: a meta-analysis.糖尿病使 COVID-19 患者的死亡率增加：一项荟萃分析。

Acta Diabetol. 2021 Feb;58(2):139-144. doi: 10.1007/s00592-020-01546-0. Epub 2020 Jun 24.

Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration.分析影响 COVID-19 患者预后和病毒脱落持续时间的因素。

Epidemiol Infect. 2020 Jun 25;148:e125. doi: 10.1017/S0950268820001399.

Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens.预测感染意大利公民中严重或致命的 COVID-19 的因素，包括血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂。

PLoS One. 2020 Jun 24;15(6):e0235248. doi: 10.1371/journal.pone.0235248. eCollection 2020.

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies.糖尿病是 COVID-19 病情加重和住院死亡的危险因素：观察性研究的荟萃分析。

Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1236-1248. doi: 10.1016/j.numecd.2020.05.014. Epub 2020 May 29.

Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China.临床特征、相关因素和预测 COVID-19 死亡率风险：中国武汉的回顾性研究。

Am J Prev Med. 2020 Aug;59(2):168-175. doi: 10.1016/j.amepre.2020.05.002. Epub 2020 May 27.

Anticardiolipin IgG Autoantibody Level Is an Independent Risk Factor for COVID-19 Severity.抗心磷脂IgG自身抗体水平是新冠病毒疾病严重程度的独立危险因素。

Arthritis Rheumatol. 2020 Nov;72(11):1953-1955. doi: 10.1002/art.41409. Epub 2020 Sep 22.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验